Samsung Biologics poised for growth pending BIOSECURE bill approval in US
The US government’s unveiling of the BIOSECURE bill has created a great deal of discussion and debate in the pharma industry.
The US government’s unveiling of the BIOSECURE bill has created a great deal of discussion and debate in the pharma industry.
We sat down with Jay Ferguson, director at Houlihan Lokey's Healthcare Group, to discuss why he views the pharma services sector as a highly promising investment opportunity. He outlines his prediction that a confluence of tailwinds is set to sustain...
Broken String Biosciences, a genomics company driving cell and gene therapy developing, has entered a research collaboration with the Francis Crick Institute, a biomedical discovery institute dedicated to understanding the biology underlying health and...